# Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples

> **NCT03663400** · — · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 47 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DIAGNOSTIC_TEST:** GWAS analysis by Illumina BeadChip

## Key facts

- **NCT ID:** NCT03663400
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-04
- **Primary completion:** 2022-03-24
- **Final completion:** 2022-03-24
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2022-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03663400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03663400, "Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03663400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*